Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Mesothelioma

Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype

Xuerao Ning, Thảo Thi Thanh Nguyễn, Takao Morinaga, Yuji Tada, Hideaki Shimada, Kenzo Hiroshima, Naoto Yamaguchi, Masatoshi Tagawa

published 23 Feb 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors

Masaki Ito, Shigeo Koido, Takeo Iwamoto, Soyoko Morimoto, Fumihiro Fujiki, Haruo Sugiyama, Saki Matsumoto, Clara Effenberger, Kazuma Kiyotani, Kiyotaka Shiba

published 08 Aug 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study

Jolien Van den Bossche, Maxime De Laere, Koen Deschepper, Paul Germonpré, Yvan Valcke, Jan Lamont, Barbara Stein, Kirsten Van Camp, Charlotte Germonpré, Griet Nijs, Ella Roelant, Sébastien Anguille, Eva Lion, Zwi Berneman

published 15 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Efficacy and safety profile of combining antiangiogenic agents with chemotherapy in patients with advanced malignant pleural mesothelioma: A systematic review and meta-analysis of randomized controlled trials

Wei Tian, Qian Guo, Daidi Fu, Xiao Ma, Rui Wang

published 21 Dec 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Reasons for stopping Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): A retrospective study to improve future patient selection

Anne-Cécile Ezanno, Brice Malgras, Pierre-Louis Conan, Adeline Aime, Jade Fawaz, Hugo Picchi, Solène Doat, Marc Pocard

published 30 Nov 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma

M. Lizeth Orozco Morales, Catherine A. Rinaldi, Emma de Jong, Sally M. Lansley, Y. C. Gary Lee, Rachael M. Zemek, Anthony Bosco, Richard A. Lake, W. Joost Lesterhuis

published 05 May 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Assessment of miR-103a-3p in leukocytes—No diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis

Carmina Jiménez-Ramírez, Daniel Gilbert Weber, Guadalupe Aguilar-Madrid, Alexander Brik, Cuauhtémoc Arturo Juárez-Pérez, Swaantje Casjens, Irina Raiko, Thomas Brüning, Georg Johnen, Alejandro Cabello-López

published 14 Oct 2022

Loading metrics information...

Metrics unavailable. Please check back later.

A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma

Xiao Wang, Sharyn Katz, John Miura, Giorgos Karakousis, Leonid Roshkovan, Suzanne Walker, Sally McNulty, Christine Ciunci, Keith Cengel, Corey J. Langer, Melina E. Marmarelis

published 29 Sep 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Cytomegalovirus infection in malignant pleural mesothelioma

DeVon Hunter-Schlichting, Karl T. Kelsey, Ryan Demmer, Manish Patel, Raphael Bueno, Brock Christensen, Naomi Fujioka, Deepa Kolarseri, Heather H. Nelson

published 12 Aug 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma

Jun Hyeok Lim, Joon Young Choi, Yunjoo Im, Hongseok Yoo, Byung Woo Jhun, Byeong-Ho Jeong, Hye Yun Park, Kyungjong Lee, Hojoong Kim, O Jung Kwon, Joungho Han, Myung-Ju Ahn, Jhingook Kim, Sang-Won Um

published 18 Feb 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Computational prediction of diagnosis and feature selection on mesothelioma patient health records

Davide Chicco, Cristina Rovelli

published 10 Jan 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents

Raffaella Cincinelli, Loana Musso, Roberto Artali, Mario B. Guglielmi, Ilaria La Porta, Carmela Melito, Fabiana Colelli, Francesco Cardile, Giacomo Signorino, Alessandra Fucci, Martina Frusciante, Claudio Pisano, Sabrina Dallavalle

published 09 Oct 2018

Loading metrics information...

Metrics unavailable. Please check back later.

BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state

Emma M. Rath, Yuen Yee Cheng, Mark Pinese, Kadir H. Sarun, Amanda L. Hudson, Christopher Weir, Yiwei D. Wang, Anders P. Håkansson, Viive M. Howell, Guo Jun Liu, Glen Reid, Robert B. Knott, Anthony P. Duff, W. Bret Church

published 29 Aug 2018

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Mesothelioma

You can change these options by clicking profile then "Alerts and Notifications"